Bal Pharma will hold a meeting of the Board of Directors of the Company on 28 May 2024.Powered by Capital Market - Live News

Net profit of Bal Pharma rose 56.14% to Rs 0.89 crore in the quarter ended December 2023 as against Rs 0.57 crore during the previous quarter ended December 2022. Sales rose 6.58% to Rs 81.66 crore in the quarter ended December 2023 as against Rs 76.62 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales81.6676.62 7 OPM %9.548.03 - PBDT4.233.50 21 PBT1.271.05 21 NP0.890.57 56 Powered by Capital Market - Live News

Bal Pharma will hold a meeting of the Board of Directors of the Company on 12 February 2024.Powered by Capital Market - Live News

Bal Pharma announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 21 December 2023 .Powered by Capital Market - Live News

Net profit of Bal Pharma rose 763.64% to Rs 0.95 crore in the quarter ended September 2023 as against Rs 0.11 crore during the previous quarter ended September 2022. Sales rose 22.88% to Rs 92.54 crore in the quarter ended September 2023 as against Rs 75.31 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales92.5475.31 23 OPM %8.327.66 - PBDT4.022.97 35 PBT1.600.60 167 NP0.950.11 764 Powered by Capital Market - Live News